ARCA Biopharma rises on review of strategic options

Oruka Therapeutics

18/04/2022 23:07

** Shares of biopharma co  ABIO.O  up ~6% at $2.45 after the
bell 
    ** ABIO says board has setup special committee to evaluate
strategic options  urn:newsml:reuters.com:*:nGNX5GVW5Q 
    ** Believes there are multiple potential opportunities to
enhance value for ABIO's stockholders
    ** Says special committee includes current board chairman
Robert Conway
    ** Last month, co's experimental COVID drug failed to meet
main goal in mid-stage study  urn:newsml:reuters.com:*:nGNX2V00R 
    ** Up to Monday's close, ABIO up ~8% YTD 

 (Reporting by Bhanvi Satija in Bengaluru)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))